The Journal of Clinical Psychiatry

Page 247

More JCP Articles

Educational Activity

Early Recognition and Diagnosis of Multiple Sclerosis

April 15, 2012

Emmanuelle Waubant

Review Article

Does the Presence of an Open-Label Antidepressant Treatment Period Influence Study Outcome in Clinical Trials Examining Augmentation/Combination Strategies in Treatment Partial Responders/Nonresponders With Major Depressive Disorder?

April 3, 2012

Nadia Iovieno , George I. Papakostas

Original Research

Differences Among Major Depressive Disorder With and Without Co-occurring Substance Use Disorders and Substance-Induced Depressive Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

March 20, 2012

Carlos Blanco , Analucía A. Alegría , Shang-Min Liu , et al

Original Research

New Evidence for the Involvement of Mitochondrial Inheritance in Schizophrenia: Results From a Cross-Sectional Study Evaluating the Risk of Illness in Relatives of Schizophrenia Patients

March 20, 2012

Begoña Verge , Yolanda Alonso , Carmen Miralles , et al

Original Research

Relationship Between Serum Homocysteine Levels and Depressive Symptoms: The Cooper Center Longitudinal Study

March 20, 2012

Phillip Gu , Laura F. DeFina , David Leonard , et al

Original Research

Relationship of Prior Antidepressant Exposure to Long-Term Prospective Outcome in Bipolar I Disorder Outpatients

March 20, 2012

Robert M. Post , Gabriele S. Leverich , Lori L. Altshuler , et al

Book Review

Behavioral and Psychopharmacologic Pain Management

March 15, 2012

Thomas N. Wise

Commentary

Benzodiazepines, Posttraumatic Stress Disorder, and Veterans: Good News and Why We’ re Not Done Yet

March 15, 2012

Bruce P. Capehart

Commentary

Emerging Bias in the Treatment of Posttraumatic Stress Disorder

March 15, 2012

David C. Emelity

Correction

Correction: Challenges and Solutions in Developing New Medications for Schizophrenia

March 15, 2012

Original Research

Cost-Effectiveness of 12-Month Therapeutic Assertive Community Treatment as Part of Integrated Care Versus Standard Care in Patients With Schizophrenia Treated With Quetiapine Immediate Release (ACCESS Trial)

March 15, 2012

Anne Karow , Jens Reimer , Hans Helmut König , et al

Book Review

Handbook of Clinical Sexuality for Mental Health Professionals, 2nd ed

March 15, 2012

Jeanne M. Lackamp

« 1 … 245 246 247 248 249 … 759 »

Early Recognition and Diagnosis of Multiple Sclerosis

Does the Presence of an Open-Label Antidepressant Treatment Period Influence Study Outcome in Clinical Trials Examining Augmentation/Combination Strategies in Treatment Partial Responders/Nonresponders With Major Depressive Disorder?

Differences Among Major Depressive Disorder With and Without Co-occurring Substance Use Disorders and Substance-Induced Depressive Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

New Evidence for the Involvement of Mitochondrial Inheritance in Schizophrenia: Results From a Cross-Sectional Study Evaluating the Risk of Illness in Relatives of Schizophrenia Patients

Relationship Between Serum Homocysteine Levels and Depressive Symptoms: The Cooper Center Longitudinal Study

Relationship of Prior Antidepressant Exposure to Long-Term Prospective Outcome in Bipolar I Disorder Outpatients

Behavioral and Psychopharmacologic Pain Management

Benzodiazepines, Posttraumatic Stress Disorder, and Veterans: Good News and Why We’ re Not Done Yet

Emerging Bias in the Treatment of Posttraumatic Stress Disorder

Correction: Challenges and Solutions in Developing New Medications for Schizophrenia

Cost-Effectiveness of 12-Month Therapeutic Assertive Community Treatment as Part of Integrated Care Versus Standard Care in Patients With Schizophrenia Treated With Quetiapine Immediate Release (ACCESS Trial)

Handbook of Clinical Sexuality for Mental Health Professionals, 2nd ed

ELSEWHERE:

FOLLOW US:

More JCP Articles

Early Recognition and Diagnosis of Multiple Sclerosis

Does the Presence of an Open-Label Antidepressant Treatment Period Influence Study Outcome in Clinical Trials Examining Augmentation/Combination Strategies in Treatment Partial Responders/Nonresponders With Major Depressive Disorder?

Differences Among Major Depressive Disorder With and Without Co-occurring Substance Use Disorders and Substance-Induced Depressive Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

New Evidence for the Involvement of Mitochondrial Inheritance in Schizophrenia: Results From a Cross-Sectional Study Evaluating the Risk of Illness in Relatives of Schizophrenia Patients

Relationship Between Serum Homocysteine Levels and Depressive Symptoms: The Cooper Center Longitudinal Study

Relationship of Prior Antidepressant Exposure to Long-Term Prospective Outcome in Bipolar I Disorder Outpatients

Behavioral and Psychopharmacologic Pain Management

Benzodiazepines, Posttraumatic Stress Disorder, and Veterans: Good News and Why We’ re Not Done Yet

Emerging Bias in the Treatment of Posttraumatic Stress Disorder

Correction: Challenges and Solutions in Developing New Medications for Schizophrenia

Cost-Effectiveness of 12-Month Therapeutic Assertive Community Treatment as Part of Integrated Care Versus Standard Care in Patients With Schizophrenia Treated With Quetiapine Immediate Release (ACCESS Trial)

Handbook of Clinical Sexuality for Mental Health Professionals, 2nd ed

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles